Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,270
Closed -$209K 210
2026
Q1
$209K Buy
+4,270
New +$199K ﹤0.01% 656
2022
Q4
Sell
-2,552
Closed -$96K 638
2022
Q3
$96K Sell
2,552
-88
-3% -$3.89K ﹤0.01% 420
2022
Q2
$120K Sell
2,640
-32
-1% -$1.5K ﹤0.01% 387
2022
Q1
$127K Sell
2,672
-966
-27% -$40.9K ﹤0.01% 402
2021
Q4
$150K Buy
3,638
+356
+11% +$13.4K ﹤0.01% 397
2021
Q3
$113K Buy
3,282
+2,804
+587% +$95.8K ﹤0.01% 410
2021
Q2
$15K Sell
478
-136
-22% -$4.38K ﹤0.01% 695
2021
Q1
$19K Buy
614
+133
+28% +$4K ﹤0.01% 598
2020
Q4
$15K Buy
481
+107
+29% +$3.16K ﹤0.01% 526
2020
Q3
$10K Sell
374
-52
-12% -$1.38K ﹤0.01% 561
2020
Q2
$11K Buy
426
+137
+47% +$3.64K ﹤0.01% 538
2020
Q1
$7.6K Sell
289
-262
-48% -$8.24K ﹤0.01% 545
2019
Q4
$17.9K Sell
551
-43
-7% -$1.39K ﹤0.01% 617
2019
Q3
$20.5K Buy
+594
New +$19.9K ﹤0.01% 651

Other funds holding EXC

Evoke Wealth's EXC Position: Q2 2026 in Review

Evoke Wealth sold out of Exelon (EXC) in Q2 2026, closing a stake of 4,270 shares — an estimated $209K sold.

Evoke Wealth first reported a position in EXC in Q3 2019 and held it in 14 quarters. The position peaked at $209K in Q1 2026. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Evoke Wealth reported no remaining Exelon position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 4,270 Exelon shares in Q2 2026, an estimated $209K.
  • Evoke Wealth first reported a position in Exelon in Q3 2019 and held it in 14 quarters.
  • Evoke Wealth's Exelon position peaked at $209K in Q1 2026.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.